Literature DB >> 8329428

Successful treatment of Mycoplasma mediastinitis after heart-lung transplantation.

E M Boyle1, J Burdine, R M Bolman.   

Abstract

Mycoplasma hominis and Ureaplasma urealyticum are members of the Mycoplasma genus that can infect surgical wounds. These organisms are rarely cultured by conventional laboratory techniques, and they respond poorly to commonly used broad-spectrum antibiotics. Including this case, five cases of Mycoplasma mediastinitis have been reported, three of which followed heart-lung transplantation. Successful treatment of Mycoplasma mediastinitis after heart-lung transplantation was achieved in this patient with extensive debridement, muscle-flap coverage, and long-term antibiotics. Possible sources of this infection after heart-lung transplantation and treatment options are discussed.

Entities:  

Mesh:

Year:  1993        PMID: 8329428

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  4 in total

Review 1.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

2.  Ureaplasma parvum as a cause of sternal wound infection.

Authors:  Andrew Walkty; Evelyn Lo; Kanchana Manickam; Michelle Alfa; Li Xiao; Ken Waites
Journal:  J Clin Microbiol       Date:  2009-04-15       Impact factor: 5.948

3.  Mycoplasma hominis Induces Mediastinitis after a Tonsillar Abscess.

Authors:  Anna Grancini; Manuela Colosimo; Antonella Restelli; Rosaria Colombo; Anna Maraschini; Cristina Pozzi; Giuseppe Breda; Alessandro Protti; Milena Arghittu; Luca Gallelli; Rita Maiavacca
Journal:  Case Rep Infect Dis       Date:  2016-11-10

4.  Cardiothoracic Transplant Recipient Mycoplasma hominis: An Uncommon Infection with Probable Donor Transmission.

Authors:  Rahul Sampath; Robin Patel; Scott A Cunningham; Sana Arif; Richard C Daly; Andrew D Badley; Mark E Wylam
Journal:  EBioMedicine       Date:  2017-04-19       Impact factor: 8.143

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.